{"drugs":["Bactroban","Mupirocin Calcium"],"mono":{"0":{"id":"923578-s-0","title":"Generic Names","mono":"Mupirocin Calcium"},"1":{"id":"923578-s-1","title":"Dosing and Indications","sub":{"0":{"id":"923578-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Methicillin resistant Staphylococcus aureus infection, Nasal colonization:<\/b> intranasal ointment, apply one-half of single-use 1 g tube into each nostril TOPICALLY twice daily for 5 days<\/li><li><b>Secondary infection - Skin lesion:<\/b> apply 2% cream TOPICALLY 3 times per day for 10 days<\/li><\/ul>"},"1":{"id":"923578-s-1-5","title":"Pediatric Dosing","mono":"<ul><li><b>Methicillin resistant Staphylococcus aureus infection, Nasal colonization:<\/b> (12 years of age and older) intranasal ointment, apply one-half of single-use 1 g tube into each nostril TOPICALLY twice daily for 5 days<\/li><li><b>Secondary infection - Skin lesion:<\/b> (3 months and older) apply 2% cream TOPICALLY 3 times per day for 10 days<\/li><\/ul>"},"3":{"id":"923578-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Methicillin resistant Staphylococcus aureus infection, Nasal colonization<\/li><li>Secondary infection - Skin lesion<\/li><\/ul><b>Non-FDA Labeled Indications<\/b><br\/>Superficial bacterial infection of skin<br\/>"}}},"3":{"id":"923578-s-3","title":"Contraindications\/Warnings","sub":[{"id":"923578-s-3-9","title":"Contraindications","mono":"Hypersensitivity to mupirocin calcium or to any component of the product <br\/>"},{"id":"923578-s-3-10","title":"Precautions","mono":"<ul><li>Dermatologic:<\/li><li>-- Systemic allergic reactions, including urticaria and generalized rash, have been reported<\/li><li>-- Discontinue use if sensitization or severe local irritation occur<\/li><li>Gastrointestinal:<\/li><li>-- Clostridium difficile-associated diarrhea has been reported, including cases occurring more than 2 months after administration; evaluate and institute appropriate medical management if suspected or confirmed; discontinuation may be warranted<\/li><li>-- Cream not recommended for use on mucosal surfaces<\/li><li>Immunologic:<\/li><li>-- Systemic allergic reactions, including anaphylaxis, have been reported<\/li><li>Ophthalmic:<\/li><li>-- Avoid contact with eyes and rinse thoroughly if accidental contact occurs<\/li><li>-- Overgrowth of nonsusceptible organisms, including fungi, may occur with prolonged therapy<\/li><li>Other:<\/li><li>-- Systemic allergic reactions, including angioedema, have been reported<\/li><li>Concomitant use:<\/li><li>-- Avoid use of mupirocin nasal ointment with other intranasal products<\/li><\/ul>"},{"id":"923578-s-3-11","title":"Pregnancy Category","mono":"<ul><li>Mupirocin: B (FDA)<\/li><li>Mupirocin: B1 (AUS)<\/li><\/ul>"},{"id":"923578-s-3-12","title":"Breast Feeding","mono":"Mupirocin: Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"923578-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Dermatologic:<\/b>Pruritus (1% nasal ointment; 2.4% cream), Rash (1%)<\/li><li><b>Gastrointestinal:<\/b>Nausea (1.1% to 4.9% cream; less than 1% nasal ointment)<\/li><li><b>Neurologic:<\/b>Headache (1.7% to 3.6% cream; 9% nasal ointment)<\/li><li><b>Respiratory:<\/b>Disorder of respiratory system (5% nasal ointment), Pharyngitis (4% nasal ointment), Rhinitis (6% nasal ointment)<\/li><\/ul><b>Serious<\/b><ul><li><b>Gastrointestinal:<\/b>Clostridium difficile diarrhea<\/li><li><b>Immunologic:<\/b>Anaphylaxis, Hypersensitivity reaction<\/li><\/ul>"},"6":{"id":"923578-s-6","title":"Drug Name Info","sub":{"0":{"id":"923578-s-6-17","title":"US Trade Names","mono":"Bactroban<br\/>"},"2":{"id":"923578-s-6-19","title":"Class","mono":"<ul><li>Antibacterial<\/li><li>Antibiotic<\/li><\/ul>"},"3":{"id":"923578-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"923578-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"9":{"id":"923578-s-9","title":"Administration","mono":"<ul><li><b>Nasal<\/b><br\/><ul><li>apply morning and evenings<\/li><li>after application, press nostrils together and release repeatedly for 1 minute to spread ointment throughout the nares<\/li><li>discard tube after use; do not re-use<\/li><li>do not use concurrently with any other intranasal products<\/li><\/ul><\/li><li><b>Topical<\/b><br\/><ul><li>may cover treated areas with gauze dressings if desired<\/li><li>avoid contact with eyes<\/li><\/ul><\/li><\/ul>"},"10":{"id":"923578-s-10","title":"Monitoring","mono":"<ul><li>clearing of infected skin (topical cream).<\/li><li>Eradication of colonization (nasal ointment)<\/li><li>re-evaluate patients who have not shown a clinical response within 3 to 5 days of starting therapy (topical cream).<\/li><li>evidence of sensitization or severe local irritation.<\/li><\/ul>"},"11":{"id":"923578-s-11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/>Topical Cream: 2 %<br\/><\/li><li><b>Bactroban<\/b><br\/><ul><li>Nasal Ointment: 2 %<\/li><li>Topical Cream: 2 %<\/li><\/ul><\/li><\/ul>"},"13":{"id":"923578-s-13","title":"Clinical Teaching","mono":"<ul><li>Advise patient to report symptoms of Clostridium difficile-associated diarrhea, including up to 2 months after therapy.<\/li><li>Direct patient to report symptoms of sensitization or severe local irritation.<\/li><li>Intranasal side effects may include headaches, rhinitis, upper respiratory tract congestion, pharyngitis, taste perversion, burning, stinging, cough, or pruritus.<\/li><li>Topical side effects may include burning, cellulitis, pruritus, rash, or nausea.<\/li><li>Tell patient to keep drug away from the eyes; if this occurs, rinse eyes with water.<\/li><\/ul>"}}}